Search
FDA Grants Rare Pediatric Designation to Treatment With NEO100 in Brain Cancer
- OPACC
- Apr 10
- 1 min read
The FDA has granted Rare Pediatric Disease Designation for NEO100 in the treatment of pediatric-type diffuse high-grade gliomas, a type of brain cancer.
Comments